These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18197673)

  • 1. Successful control of aggregation and folding rates during refolding of denatured lysozyme by adding N-methylimidazolium cations with various N'-substituents.
    Yamaguchi S; Yamamoto E; Tsukiji S; Nagamune T
    Biotechnol Prog; 2008; 24(2):402-8. PubMed ID: 18197673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionic liquids as refolding additives: N'-alkyl and N'-(omega-hydroxyalkyl) N-methylimidazolium chlorides.
    Lange C; Patil G; Rudolph R
    Protein Sci; 2005 Oct; 14(10):2693-701. PubMed ID: 16195554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein refolding by N-alkylpyridinium and N-alkyl-N-methylpyrrolidinium ionic liquids.
    Yamamoto E; Yamaguchi S; Nagamune T
    Appl Biochem Biotechnol; 2011 Jul; 164(6):957-67. PubMed ID: 21302144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the effects of solution additives on heat- and refolding-induced aggregation.
    Hamada H; Takahashi R; Noguchi T; Shiraki K
    Biotechnol Prog; 2008; 24(2):436-43. PubMed ID: 18386919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of detergents and organic solvents on protein refolding: control of aggregation and folding rates.
    Yamamoto E; Yamaguchi S; Nagamune T
    J Biosci Bioeng; 2011 Jan; 111(1):10-5. PubMed ID: 20855233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indispensable structure of solution additives to prevent inactivation of lysozyme for heating and refolding.
    Matsuoka T; Hamada H; Matsumoto K; Shiraki K
    Biotechnol Prog; 2009; 25(5):1515-24. PubMed ID: 19774664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refolding kinetics of denatured-reduced lysozyme in the presence of folding aids.
    Dong XY; Huang Y; Sun Y
    J Biotechnol; 2004 Oct; 114(1-2):135-42. PubMed ID: 15464607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysozyme refolding with cyclodextrins: structure-activity relationship.
    Desai A; Lee C; Sharma L; Sharma A
    Biochimie; 2006 Oct; 88(10):1435-45. PubMed ID: 16737767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of additives on refolding of a denatured protein.
    Yasuda M; Murakami Y; Sowa A; Ogino H; Ishikawa H
    Biotechnol Prog; 1998; 14(4):601-6. PubMed ID: 9694682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling and simulation of fed-batch protein refolding process.
    Dong XY; Shi GQ; Li W; Sun Y
    Biotechnol Prog; 2004; 20(4):1213-9. PubMed ID: 15296450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new kinetic scheme for lysozyme refolding and aggregation.
    Buswell AM; Middelberg AP
    Biotechnol Bioeng; 2003 Sep; 83(5):567-77. PubMed ID: 12827698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-argininamide improves the refolding more effectively than L-arginine.
    Hamada H; Shiraki K
    J Biotechnol; 2007 Jun; 130(2):153-60. PubMed ID: 17434637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionic liquids as refolding additives: variation of the anion.
    Buchfink R; Tischer A; Patil G; Rudolph R; Lange C
    J Biotechnol; 2010 Oct; 150(1):64-72. PubMed ID: 20630486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-pressure refolding of disulfide-cross-linked lysozyme aggregates: thermodynamics and optimization.
    St John RJ; Carpenter JF; Randolph TW
    Biotechnol Prog; 2002; 18(3):565-71. PubMed ID: 12052074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein refolding assisted by periodic mesoporous organosilicas.
    Wang X; Lu D; Austin R; Agarwal A; Mueller LJ; Liu Z; Wu J; Feng P
    Langmuir; 2007 May; 23(10):5735-9. PubMed ID: 17402759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A metal binding in the polypeptide chain improves the folding efficiency of a denatured and reduced protein.
    Ohkuri T; Ueda T; Yoshida Y; Abe Y; Hamasaki N; Imoto T
    Biopolymers; 2002 Jul; 64(2):106-14. PubMed ID: 11979521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysozyme refolding at high concentration by dilution and size-exclusion chromatography.
    Goa YG; Guan YX; Yao SJ; Cho MG
    J Zhejiang Univ Sci; 2003; 4(2):136-41. PubMed ID: 12659225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazole as a catalyst for in vitro refolding of enhanced green fluorescent protein.
    Shi R; Pan Q; Guan Y; Hua Z; Huang Y; Zhao M; Li Y
    Arch Biochem Biophys; 2007 Mar; 459(1):122-8. PubMed ID: 17169325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refolding of partially and fully denatured lysozymes.
    Lin JL; Ruaan RC; Hsieh HJ
    Biotechnol Lett; 2007 May; 29(5):723-9. PubMed ID: 17310324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical assessment of the impact of mixing on dilution refolding.
    Mannall GJ; Titchener-Hooker NJ; Chase HA; Dalby PA
    Biotechnol Bioeng; 2006 Apr; 93(5):955-63. PubMed ID: 16353172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.